Reporting Compliance. During the Term, in the event that Intrexon notifies Fibrocell that Intrexon has reasonably concluded, after consultation with its outside advisors, that Intrexon will have to consolidate Fibrocell’s financial statements with its own, for so long as Intrexon reasonably believes that such consolidation is necessary, Fibrocell shall comply with the following additional obligations:
Appears in 5 contracts
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Fibrocell Science, Inc.), Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)